Evidence map›Paper›PMID 36380882›Full record

ReviewJAC-antimicrobial resistance2022

Introducing the global antimicrobial stewardship partnership hub (GASPH): creating conditions for successful global partnership collaboration.

Jacqueline Sneddon, Tracey Guise, David Jenkins, Mirfin Mpundu, Maarten Van Dongen, Jeroen Schouten, Jonghong Xiao, Gloria Cordoba, Dilip Nathwani

Abstract readReview
In one paragraph

Review in JAC-antimicrobial resistance, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Jacqueline SneddonBritish Society for Antimicrobial Chemotherapy, Birmingham, UK.
Tracey GuiseBritish Society for Antimicrobial Chemotherapy, Birmingham, UK.
David JenkinsBritish Society for Antimicrobial Chemotherapy, Birmingham, UK.
Mirfin MpunduReAct Africa, Lusaka, Zambia.
Maarten Van DongenAMR Insights, Amsterdam, The Netherlands.
Jeroen SchoutenDepartment of Intensive Care and Radboudumc Center for Infectious Diseases, European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group on Antimicrobial Stewardship (ESGAP), Nijmegen, The Netherlands.
Jonghong XiaoSchool of Medicine, Zhejiang University, Hangzhou, China.
Gloria CordobaInternational Centre for Antimicrobial Resistance Solutions, Copenhagen, Denmark.
Dilip NathwaniBritish Society for Antimicrobial Chemotherapy, Birmingham, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In 2015, 196 countries formally committed to a Global Action Plan to address antimicrobial resistance (AMR). However, translating policy into practice is not happening at pace and the recent Global Research on AntiMicrobial resistance (GRAM) Project report confirms the burden of AMR is increasing. Despite progress in establishing surveillance data and investment in new antimicrobials, education and training including use of behavioural science approaches to change practice is lagging. To contribute to addressing this, we have invited organizations to join us as founding members of the Global Antimicrobial Stewardship Partnership Hub (GASPH) (https://global-asp-hub.com/). We will work together to share education resources and foster collaboration to meet the needs of learners and of partner organizations working on tackling AMR. Membership is open to all-professional societies, academic institutes, nongovernmental organizations/civil society, philanthropists and commercial partners interested in supporting a multi-stakeholder global antimicrobial stewardship (AMS) education platform and network.

Identifiers

PMID36380882
PMCPMC9642107

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.